XML 65 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Financial Information of the Parent Company
12 Months Ended
Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]  
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY
25.
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY

Condensed Balance Sheets

 

 

 

As of December 31,

 

 

 

Note

 

 

2023

 

 

2024

 

 

2024

 

 

 

 

 

 

RMB

 

 

RMB

 

 

US$

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

401,002

 

 

 

887,386

 

 

 

121,571

 

Prepayments and other assets

 

 

 

 

 

4,725

 

 

 

2,543

 

 

 

348

 

Amounts due from entities within the Group

 

 

 

 

 

22,653,118

 

 

 

21,082,425

 

 

 

2,888,281

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total current assets

 

 

 

 

 

23,058,845

 

 

 

21,972,354

 

 

 

3,010,200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total non-current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

 

 

23,058,845

 

 

 

21,972,354

 

 

 

3,010,200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Convertible senior notes

 

 

 

 

 

2,802,442

 

 

 

242,460

 

 

 

33,217

 

Accrued expenses and other liabilities

 

 

 

 

 

25,891

 

 

 

13,898

 

 

 

1,904

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

 

 

 

2,828,333

 

 

 

256,358

 

 

 

35,121

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Convertible senior notes

 

 

14

 

 

 

8,143,994

 

 

 

8,350,570

 

 

 

1,144,023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total non-current liabilities

 

 

 

 

 

8,143,994

 

 

 

8,350,570

 

 

 

1,144,023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

 

 

 

10,972,327

 

 

 

8,606,928

 

 

 

1,179,144

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

17

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

Class A ordinary shares (US$0.00001 par value; 94,000,000,000 
      shares authorized as of December 31, 2023 and 2024,
      respectively;
3,853,820,658 and 3,854,584,680 shares
      issued as of December 31, 2023 and 2024, respectively;
      
3,675,039,807 and 3,698,793,887 shares outstanding
      as of December 31, 2023 and 2024, respectively)

 

 

18

 

 

 

237

 

 

 

238

 

 

 

33

 

Class B ordinary shares (US$0.00001 par value; 5,000,000,000 
      shares authorized as of December 31, 2023 and 2024;
      
3,041,097,278 shares issued and outstanding
      as of December 31, 2023 and 2024)

 

 

18

 

 

 

193

 

 

 

193

 

 

 

26

 

Additional paid-in capital

 

 

 

 

 

54,971,469

 

 

 

55,623,841

 

 

 

7,620,435

 

Accumulated deficit

 

 

19

 

 

 

(44,573,428

)

 

 

(43,809,369

)

 

 

(6,001,859

)

Accumulated other comprehensive income

 

 

24

 

 

 

1,688,047

 

 

 

1,550,523

 

 

 

212,421

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total shareholders’ equity

 

 

 

 

 

12,086,518

 

 

 

13,365,426

 

 

 

1,831,056

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities and shareholders’ equity

 

 

 

 

 

23,058,845

 

 

 

21,972,354

 

 

 

3,010,200

 

 

Condensed Statements of Comprehensive (Loss)/Income

 

 

Year ended December 31,

 

 

 

2022

 

 

2023

 

 

2024

 

 

2024

 

 

 

RMB

 

 

RMB

 

 

RMB

 

 

US$

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

(66,883

)

 

 

(11,397

)

 

 

(13,814

)

 

 

(1,893

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating loss

 

 

 

 

 

 

 

 

 

 

 

 

Share of income of subsidiaries, VIEs and VIEs’ subsidiaries

 

 

2,076,676

 

 

 

2,975,000

 

 

 

1,844,679

 

 

 

252,720

 

Interest income

 

 

12,845

 

 

 

115,209

 

 

 

59,742

 

 

 

8,185

 

Interest expenses

 

 

(234,870

)

 

 

(726,487

)

 

 

(672,647

)

 

 

(92,152

)

Foreign exchange loss, net

 

 

(1,954,314

)

 

 

(665,335

)

 

 

(640,334

)

 

 

(87,725

)

Others, net

 

 

30,334

 

 

 

238,479

 

 

 

186,433

 

 

 

25,541

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss)/income

 

 

(136,212

)

 

 

1,925,469

 

 

 

764,059

 

 

 

104,676

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss)/income attributable to ordinary shareholders

 

 

(136,212

)

 

 

1,925,469

 

 

 

764,059

 

 

 

104,676

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(849,395

)

 

 

(164,040

)

 

 

(134,533

)

 

 

(18,431

)

Unrealized losses on available-for-sale debt securities

 

 

(21,091

)

 

 

(11,367

)

 

 

(2,991

)

 

 

(410

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive loss, net of tax

 

 

(870,486

)

 

 

(175,407

)

 

 

(137,524

)

 

 

(18,841

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive (loss)/income

 

 

(1,006,698

)

 

 

1,750,062

 

 

 

626,535

 

 

 

85,835

 

 

Condensed Statements of Cash Flows

 

 

 

Year ended December 31,

 

 

 

2022

 

 

2023

 

 

2024

 

 

2024

 

 

 

RMB

 

 

RMB

 

 

RMB

 

 

US$

 

Net cash used for operating activities

 

 

(157,273

)

 

 

(370,682

)

 

 

(35,985

)

 

 

(4,930

)

Net cash (used for)/provided by investing activities

 

 

(2,462,807

)

 

 

238,001

 

 

 

3,384,507

 

 

 

463,676

 

Net cash provided by/(used for) financing activities

 

 

5,307,603

 

 

 

(3,859,442

)

 

 

(2,873,166

)

 

 

(393,622

)

Effect of exchange rate changes on cash and cash equivalents

 

 

31,492

 

 

 

58,157

 

 

 

11,028

 

 

 

1,510

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

 

2,719,015

 

 

 

(3,933,966

)

 

 

486,384

 

 

 

66,634

 

Cash and cash equivalents at the beginning of the year

 

 

1,615,953

 

 

 

4,334,968

 

 

 

401,002

 

 

 

54,937

 

Cash and cash equivalents at the end of the year

 

 

4,334,968

 

 

 

401,002

 

 

 

887,386

 

 

 

121,571

 

 

Basis of presentation

For the presentation of the parent company only condensed financial information, the Company records its investments in subsidiaries and VIEs under the equity method of accounting as prescribed in ASC 323. The subsidiaries, VIEs and VIEs’ subsidiaries losses are reported as “Share of income of subsidiaries, VIEs and VIEs’ subsidiaries” on the condensed statements of comprehensive (loss)/income. Under the equity method of accounting, the Company’s carrying amount of its investment in subsidiaries, VIEs and VIEs’ subsidiaries was reduced to nil as of December 31, 2023 and 2024, and the carrying amount of “Amounts due from entities within the Group” was further adjusted as the Company committed to provide financial support to its VIEs as disclosed in Note 1.

The subsidiaries did not pay any dividends to the Company for the periods presented.

The Company does not have significant commitments or long-term obligations as of the period end other than those presented.

The parent company only financial statements should be read in conjunction with the Company’s consolidated financial statements.